First days in the life of naive human B lymphocytes infected with Epstein-Barr virus.
Published version of a preprint
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The preferred target of Epstein-Barr virus (EBV) is human resting B lymphocytes. We found that their infection induces a well-coordinated, time-driven program that starts with a substantial increase in cell volume, followed by cellular DNA synthesis after 3 days and subsequent rapid rounds of cell divisions on the next day accompanied by some DNA replication stress (DRS). Two to 3 days later, the cells decelerate and turn into stably proliferating lymphoblast cell lines. With the aid of 16 different recombinant EBV strains, we investigated the individual contributions of EBV’s multiple latent genes during early B-cell infection and found that many do not exert a detectable phenotype or contribute little to EBV’s prelatent phase. The exception is EBNA2 that is essential in governing all aspects of B-cell reprogramming. EBV relies on EBNA2 to turn the infected B lymphocytes into proliferating lymphoblasts preparing the infected host cell for the ensuing stable, latent phase of viral infection. In the early steps of B-cell reprogramming, viral latent genes other than EBNA2 are dispensable, but some, EBNA-LP, for example, support the viral program and presumably stabilize the infected cells once viral latency is established.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This refractory state is probably due to the cells’ very reduced transcriptional activity, unknown restrictions that prevent efficient viral transduction, and the cells’ rapid apoptosis within a couple of hours upon cultivation in vitro [14].”
From Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection (2021) · cites this paper as [14]
In the citing paper
“but is only the driver of initial B cell survival and proliferation, which starts four days post infection [14].”
From Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection (2021) · cites this paper as [14]
In the citing paper
“Since primary human B cells rapidly undergo apoptosis when cultured ex vivo in the absence of stimulatory factors, we infected the cells with wild-type (WT) EBV at an optimal multiplicity of infection [14] one hour after nucleofection.”
From Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection (2021) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139
Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S., & Bonner, W. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5858 · Cited by 5,438 · cited 16×
“Interestingly, short-term incubation with etoposide, a potent inducer of DDR, led to an increase in (cid”
InfluentialCauses and consequences of replication stress
Zeman, M. K., & Cimprich, K. A. (2014) · Nature Cell Biology · doi:10.1038/ncb2897 · Cited by 2,079 · cited 1×
“X staining reflects DRS rather than the cells’ response to DNA damage (49).”
ATR: an essential regulator of genome integrity
Cimprich, K. A., & Cortez, D. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2450 · Cited by 1,798 · cited 16×
“12D), suggesting that high levels of both MRE11A and SAMHD1 limit DRS (80) in this phase of viral infection and later when lymphoblastoid cell lines emerge.”
InfluentialMyc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245 · cited 1×
“EBNA2 protein likely result in extreme MYC levels that induce alternative reading frame (ARF) expression (63), which in turn activates p53 and leads to cellular senescence, cell cycle arrest, and apoptotic death (64).”
Hickson, I., Zhao, Y., Richardson, C. J., Green, S. J., Martin, N. M. B., Orr, A. I., Reaper, P. M., Jackson, S. P., Curtin, N. J., & Smith, G. C. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2727 · Cited by 1,220
Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress
Ward, I. M., & Chen, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100569200 · Cited by 1,150
Epstein–Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection
Mrozek-Gorska, P., Buschle, A., Pich, D., Schwarzmayr, T., Fechtner, R., Scialdone, A., & Hammerschmidt, W. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901314116 · Cited by 210
Self-citation
Research works printed but not linked: 100
- 10.1016/S0140-6736(64)91524-7 · DOI · Paper page
- 10.1126/science.157.3792.1064 · DOI · Paper page
- 10.1038/216810a0 · DOI
- 10.1002/ijc.2910030619 · DOI
- 10.1038/340393a0 · DOI · Paper page
- 10.1073/pnas.86.23.9558 · DOI · Paper page
- 10.1002/j.1460-2075.1995.tb06978.x · DOI · Paper page
- Kieff E, Rickinson AB. 2007. Epstein-Barr virus and its replication, p 2603–2654. In Knipe DM, Howley PM, Griffin DE, Martin MA, Lamb RA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
- 10.1128/jvi.69.1.231-238.1995 · DOI · Paper page
- 10.1073/pnas.92.13.5875 · DOI · Paper page
- 10.1093/emboj/17.6.1700 · DOI · Paper page
- 10.1073/pnas.95.14.8245 · DOI · Paper page
- 10.1186/2042-4280-1-6 · doi:10.1186/2042-4280-1-6
- Dirmeier U, Neuhierl B, Kilger E, Reisbach G, Sandberg ML, Hammerschmidt W. 2003. Latent membrane protein 1 is critical for efficient growth transformation of human B cells by Epstein-Barr virus. Cancer Res 63:2982–2989.
- 10.1371/journal.ppat.1000506 · DOI
- 10.1371/journal.pbio.0030404 · DOI · Paper page
- 10.1371/journal.ppat.1000951 · DOI · Paper page
- 10.1073/pnas.1019599108 · DOI
- 10.1371/journal.ppat.1003187 · DOI · Paper page
- 10.1073/pnas.0911948107 · DOI · Paper page
- 10.1128/JVI.06314-11 · DOI
- 10.1128/JVI.01416-06 · DOI
- 10.1073/pnas.1115906109 · DOI
- 10.1371/journal.ppat.1002704 · DOI · Paper page
- 10.1007/978-3-319-22822-8_6 · DOI
- 10.1128/JVI.00839-15 · DOI
- 10.1073/pnas.69.2.383 · DOI · Paper page
- 10.1073/pnas.70.1.190 · DOI · Paper page
- 10.1038/310207a0 · DOI · Paper page
- 10.1128/JVI.03614-14 · DOI · Paper page
- 10.1128/jvi.35.3.603-618.1980 · doi:10.1128/jvi.35.3.603-618.1980
- 10.1128/jvi.38.2.632-648.1981 · doi:10.1128/jvi.38.2.632-648.1981
- 10.1126/science.1096781 · DOI · Paper page
- 10.1016/0042-6822(90)90302-8 · DOI
- 10.1016/0092-8674(88)90028-1 · DOI · Paper page
- 10.1007/978-3-319-22822-8_4 · DOI
- 10.1126/science.1702555 · DOI · Paper page
- 10.1371/journal.pone.0001464 · DOI
- 10.1128/jvi.65.12.6826-6837.1991 · DOI · Paper page
- 10.1371/journal.ppat.1006890 · DOI
- 10.1371/journal.ppat.1001063 · DOI · Paper page
- 10.1371/journal.ppat.1001294 · DOI
- 10.7554/eLife.22509 · DOI
- 10.1016/j.chom.2010.11.004 · DOI · Paper page
- 10.1128/JVI.03568-13 · DOI
- 10.1038/nrm.2017.67 · DOI · Paper page
- 10.1021/jm301859s · DOI · Paper page
- 10.1128/jvi.69.5.3147-3155.1995 · doi:10.1128/jvi.69.5.3147-3155.1995
- 10.1038/sj.gt.3302714 · doi:10.1038/sj.gt.3302714
- 10.1128/JVI.03189-14 · DOI
- 10.1128/mBio.01482-19 · doi:10.1128/mbio.01482-19
- 10.1073/pnas.1605884113 · DOI · Paper page
- 10.1084/jem.20160248 · DOI
- 10.1073/pnas.1832776100 · DOI · Paper page
- 10.1016/j.cmet.2019.06.003 · DOI · Paper page
- 10.1128/JVI.01069-12 · DOI
- 10.1128/JVI.01178-17 · DOI
- 10.14348/molcells.2018.0100 · DOI
- Longnecker RM, Kieff E, Cohen JI. 2013. Epstein-Barr virus, p 1898–1959. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, vol 2, 6th ed. Wolters Kluver, Lippincott Williams & Wilkins, Philadelphia, PA.
- 10.1038/nm758 · DOI · Paper page
- 10.1073/pnas.0509988103 · doi:10.1073/pnas.0509988103
- 10.1007/978-3-319-22834-1_14 · DOI
- 10.1371/journal.ppat.1007039 · doi:10.1371/journal.ppat.1007039
- 10.1371/journal.ppat.1007221 · DOI
- 10.1073/pnas.1108892108 · DOI · Paper page
- 10.1016/j.bbagrm.2014.04.008 · DOI
- 10.1016/j.celrep.2013.04.002 · DOI · Paper page
- 10.1128/JVI.73.5.4481-4484.1999 · DOI · Paper page
- 10.1016/j.chom.2014.12.013 · DOI · Paper page
- 10.1146/annurev-biochem-062917-012415 · DOI · Paper page
- 10.1016/j.cell.2015.07.058 · DOI
- 10.1016/j.tim.2007.01.003 · DOI · Paper page
- 10.1371/journal.pgen.1007541 · DOI
- 10.1038/s41586-018-0050-1 · DOI · Paper page
- 10.1016/j.celrep.2019.04.020 · DOI
- 10.1038/oncsis.2017.46 · DOI
- 10.1016/j.cub.2004.09.047 · DOI · Paper page
- 10.1093/nar/gkv061 · DOI · Paper page
- 10.1091/mbc.e05-01-0065 · DOI · Paper page
- 10.1016/j.febslet.2013.08.028 · DOI · Paper page
- 10.1038/nsmb.3163 · DOI · Paper page
- 10.18632/oncotarget.14120 · DOI
- 10.1016/j.molcel.2017.07.013 · DOI · Paper page
- 10.1038/nature25507 · DOI · Paper page
- 10.1038/87730 · DOI · Paper page
- 10.1016/j.molimm.2015.07.036 · DOI · Paper page
- 10.1093/nar/gni035 · DOI · Paper page
- 10.1007/s12033-009-9142-3 · DOI · Paper page
- 10.1002/ijc.2910350404 · DOI
- 10.1182/blood-2005-06-2341 · DOI
- 10.1073/pnas.0605985103 · DOI
- 10.1128/jvi.67.4.2014-2025.1993 · DOI · Paper page
- 10.1128/jvi.77.19.10437-10447.2003 · doi:10.1128/jvi.77.19.10437-10447.2003
- 10.1128/jvi.66.5.2893-2903.1992 · doi:10.1128/jvi.66.5.2893-2903.1992
- 10.1073/pnas.0604919104 · DOI · Paper page
- 10.1128/jvi.66.11.6461-6469.1992 · doi:10.1128/jvi.66.11.6461-6469.1992
- 10.1182/blood-2007-05-090142 · DOI · Paper page
- 10.1128/jvi.67.4.2006-2013.1993 · DOI
- 10.1073/pnas.88.4.1546 · doi:10.1073/pnas.88.4.1546
- 10.1007/BF00818163 · DOI · Paper page
Cited by
Epstein–Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection
Mrozek-Gorska, P., Buschle, A., Pich, D., Schwarzmayr, T., Fechtner, R., Scialdone, A., & Hammerschmidt, W. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901314116 · Cited by 210
Self-citationAkidil, E., Albanese, M., Buschle, A., Ruhle, A., Pich, D., Keppler, O. T., & Hammerschmidt, W. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009117 · Cited by 31
Self-citationSerquiña, A. K. P., Tagawa, T., Oh, D., Mahesh, G., & Ziegelbauer, J. M. (2021) · mBio · doi:10.1128/mbio.02907-21 · Cited by 24
Metadata
- Authors
- Pich, D., Mrozek-Gorska, P., Bouvet, M., Sugimoto, A., Akidil, E., Grundhoff, A., Hamperl, S., Ling, P. D., & Hammerschmidt, W.
- Affiliations
- Research Unit Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health and German Center for Infection Research (DZIF), Munich, Germany
- Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany
- Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany
- Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2019-10-29
- Volume
- 10
- Issue
- 5
- ISSN
- 2161-2129
- 2150-7511
- Cited by
- 112
- References
- 7
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: First days in the life of naive human B lymphocytes infected with Epstein-Barr virus. https://app.cochat.ai/papers/10.1128/mbio.01723-19
- The paper
- Pich, D., Mrozek-Gorska, P., Bouvet, M., Sugimoto, A., Akidil, E., Grundhoff, A., Hamperl, S., Ling, P. D., & Hammerschmidt, W. (2019). First days in the life of naive human B lymphocytes infected with Epstein-Barr virus. mBio. https://doi.org/10.1128/mbio.01723-19
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.